Infection Control and Prevention with Non-Invasive Ventilation Equipment used with bronchiectasis, Chronic obstructive pulmonary disease, neuromuscular disorders and obesity related chronic respiratory failure: A pilot study

Royal Prince Alfred Hospital0 个研究点目标入组 40 人开始时间: 2023年8月29日最近更新: 2023年10月9日

试验速览

暂无简介。

•Subjects will be recruited from either the existing home NIV database or hospital-based ventilation undertaken by the Respiratory Support Service at Royal Prince Alfred Hospital. Patients aged 18 years or older will be eligible for inclusion if they have: a physician diagnosis of CF, non-CF bronchiectasis, COPD, obesity associated chronic respiratory failure or NMD; a history of sleep hypoventilation and/or daytime hypercapnia (arterial carbon dioxide partial pressure [PaCO2]>45 mmHg); been prescribed NIV or CPAP and are using a device with an integrated humidifier (whether humidification is used or not). Usage requirements for inclusion of home based ventilation participants will be a minimum of 4 hours per might over the past four weeks, and for acute patients, at least 12 blower hours with the last use of therapy within the previous 24 hrs on the device to be tested. Participants within the Sydney metropolitan area will be offered a home visit appointment for data collection.

•major psychiatric disorders non-compliance with therapy, unable to read and understand English, inability to understand or comply with the study requirements, or inability to give informed consent.

发起方